$75.74
-0.300 (-0.395%)
At Close: Jun 03, 2026
Henry Schein (HSIC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:08pm, Tuesday, 08'th Feb 2022
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Did Hedge Funds Catch A Break With Henry Schein, Inc. (HSIC)?
07:21pm, Monday, 07'th Feb 2022 Insider Monkey
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Zimmer Biomet (ZBH) Q4 Earnings Miss Estimates, Margins Down | Investing.com
05:40pm, Monday, 07'th Feb 2022 Investing.com
Stocks Analysis by Zacks Investment Research covering: Henry Schein Inc, Zimmer Biomet Holdings Inc, Allscripts Healthcare Solutions Inc, Healthcare Services Group Inc. Read Zacks Investment Research''s latest article on Investing.com
The Stock-Picking Puzzle: Putting The Pieces Together
03:24pm, Monday, 07'th Feb 2022
The Stock-Picking Puzzle: Putting The Pieces Together
3 Medical Products Stocks Poised to Beat This Earnings Season
11:34am, Monday, 07'th Feb 2022
The Medical Products companies' Q4 results are likely to reflect base business recovery. Let's see how BAX, HSIC, and XRAY are poised ahead of their earnings releases.
Henry Schein Medical Celebrates National Girls and Women in Sports Day
09:26pm, Wednesday, 02'nd Feb 2022 Kwhen FinanceCan Henry Schein (HSIC) Keep the Earnings Surprise Streak Alive?
01:50pm, Tuesday, 01'st Feb 2022
Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Invest in Henry Schein (HSIC) Now
10:00am, Thursday, 27'th Jan 2022
Investors are optimistic about Henry Schein's (HSIC) strong segmental performance and raised 2021 EPS guidance.
Henry Schein to Webcast Fourth Quarter and Full-Year 2021 Conference Call on Tuesday, February 15, 2022 at 10:00 A.M. ET
06:30am, Tuesday, 25'th Jan 2022
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to webcast fourth quarter and full-year 2021 conference call on February 15, 2022.
Henry Schein rises on upgrade by Credit Suisse
04:13pm, Friday, 07'th Jan 2022 Seeking AlphaHSIC vs. COO: Which Stock Should Value Investors Buy Now?
01:02pm, Thursday, 06'th Jan 2022
HSIC vs. COO: Which Stock Is the Better Value Option?
Henry Schein CFO to retire, Ronald Smith to replace him
01:53pm, Wednesday, 05'th Jan 2022 MarketWatch
Henry Schein Inc. said Tuesday that CFO Steven Paladino is set to retire in April. The medical supplier said Ronald South, the company''s chief accounting officer, will replace Paladino, reporting directly to Stanley Bergman, Henry Schein''s chair and CEO. Henry Schein''s stock is up 2.2% for the year, while the broader S&P 50 0 is up 0.5%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Henry Schein Names Ronald South CFO, Succeeding Steven Paladino, Effective April 29
11:50am, Wednesday, 05'th Jan 2022 Business Insider Markets
(RTTNews) - Henry Schein, Inc. (HSIC), a solutions company for health care professionals, announced Wednesday the appointment of Ronald South as Senior Vice President and Chief Financial Officer, effective April 29. South will succeed Steven Paladino, who plans to retire as Executive Vice President and Chief Financial Officer, effective April
Henry Schein CFO to retire, Ronald Smith to replace him
08:53am, Wednesday, 05'th Jan 2022
Henry Schein Inc. HSIC, +2.39% said Tuesday that CFO Steven Paladino is set to retire in April. The medical supplier said Ronald South, the company's chief accounting officer, will replace Paladino, r
Henry Schein: A Global Leader With A Reasonable Valuation In A Growing Market
03:36pm, Tuesday, 28'th Dec 2021
Henry Schein's leading position in the profitable and growing global dental distribution industry combined with its reasonable valuation makes it a Hold.
Sign In
Buy HSIC